MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy.
about
Early detection of diabetic kidney disease: Present limitations and future perspectivesMicroRNAs in Diabetic Kidney DiseaseMesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAsRegulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAsDirectly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder.miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1The role of microRNAs in diabetic nephropathy.Altered expression of 14-3-3ζ protein in spinal cords of rat fetuses with spina bifida apertaUrinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Altered expression of microRNA-451 in eutopic endometrium of baboons (Papio anubis) with endometriosis.MicroRNAs are exported from malignant cells in customized particles.MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.Urinary chromium is associated with changes in leukocyte miRNA expression in obese subjects.Anti-fibrosis therapy and diabetic nephropathy.Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring.MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems.Diabetic nephropathy--emerging epigenetic mechanisms.microRNAs in glomerular diseases from pathophysiology to potential treatment target.Epigenetics and Cardiovascular Disease in Diabetes.microRNAs in Diabetic Kidney Disease.MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.Epigenetics of kidney disease.The miR-30 family: Versatile players in breast cancer.miR-451 regulates dendritic cell cytokine responses to influenza infection.Towards microRNA-based therapeutics for diabetic nephropathy.Molecular signaling cascade of miRNAs in causing Diabetes Nephropathy.MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16.MicroRNA-451 down-regulates neutrophil chemotaxis via p38 MAPK.gga-miR-451 Negatively Regulates Mycoplasma gallisepticum (HS Strain)-Induced Inflammatory Cytokine Production via Targeting YWHAZ.Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
P2860
Q26741494-D1C9E083-0C44-47D7-993C-AC8612ECFCD6Q27002171-AD848D27-FF99-4A55-8C0C-982156F7413BQ27322277-35FD18CE-5FF4-4C17-A351-C05C9F17D656Q28072792-9BCDF95F-09FD-4066-BB93-8B941474392AQ30688603-1C6827A8-7373-4B5E-9039-76CA0797B3ECQ30883079-8EF6E259-D113-4928-B8CA-F5B120C1BB19Q33715064-F918CC49-A17A-42C4-87C8-2FD97011429CQ33769100-24BBF432-F5F7-4848-9AD3-425453325C45Q33865102-B4DFD420-256F-4BB7-ABD2-B344F160B669Q34195411-24149D24-B9A0-444F-8E2D-7FF399CFE4A5Q34925869-ECB4BC32-E2AF-4CAA-87F6-436F36528E18Q35996301-0167958A-5ECD-4741-9645-51A6ED31A4A8Q36166755-08C7503C-64F2-4AE6-B4C2-2BB39E763C3CQ36276318-3707D817-9340-4C32-A6AA-ABA49FC8AB00Q36305641-5FFF50DF-9E51-4D09-A524-CD143B4661B6Q37211825-AEC8AEA3-18C4-4531-BCAA-5F785C7BC177Q37493523-005C99A0-F9BE-4220-AA97-D61B452F50F6Q37575317-6842B467-54B1-4BE8-825D-2E2CEE9C8AC8Q38014361-FF357831-53DB-4A73-8CD2-A23DB1388285Q38105995-A82AA538-A075-4C4F-AA05-1F842EC8513BQ38115932-DA95C16D-468A-4F30-91B8-34804607647EQ38212459-E0317484-77F0-42ED-A2F9-5D3E8FD7D504Q38227252-2B375425-9777-423E-B374-2ED7CC82266CQ38424330-E1186E08-EA44-4D3C-AB39-E46FD81C904BQ38605096-02F93347-7C42-47EA-B31D-71582C2C72A3Q38668261-AA734929-492F-495F-87F7-7BF20A56FB6EQ38963446-42A2004D-94FF-410B-9ECA-9001F44F2B43Q39175636-49CEC6B4-7A00-42FF-897A-97A934AA6B20Q39202832-3E55B9A9-0AA6-4D89-96BE-628CE708751BQ39241429-60ADA677-3A71-4F5D-AAC5-5772BC3ECAC8Q39523597-4AE499F2-F283-4D7E-96FC-11D1CF036FC7Q41379640-8EB66C40-2CFC-4722-8E1B-DFAC2E5AEBDEQ47654272-8A6721A8-4C57-4498-8B72-29206539C0CEQ52648082-D1ECA318-ACBE-4A46-AC09-A5DC7FFA3325Q52719603-594FC758-A2E1-42FC-AE31-C4973B335BF8Q55209030-0A07C04F-4A7A-4B05-8AAA-18AFE3E4A7AEQ58795409-31F61D1F-C58C-4A16-A532-073B87536719
P2860
MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@en
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@nl
type
label
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@en
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@nl
prefLabel
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@en
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@nl
P2093
P2860
P1433
P1476
MicroRNA-451 regulates p38 MAP ...... in early diabetic nephropathy.
@en
P2093
Huimin Peng
Junxia Chen
Songtao Ding
Xiaomei Luo
Xiaoyan He
Zheng Zhang
P2860
P356
10.1016/J.FEBSLET.2011.07.042
P407
P577
2011-08-04T00:00:00Z